Table 1.

Percentage of immunopositive cells in the tumour specimens and the tumour free specimens

	Tumour		Tumour free specimens
Parameters	No. positive (%) cases	Median % positive cells (range)*	No. positive (%) cases	Median % positive cells (range)*
Number	79		66
EGFR	32 (41%)	3 (0–80)	1 (2%)	0 (0–1)
c-erbB-2	29 (37%)	10 (0–80)	3 (5%)	1 (0–30)
c-erbB-3	46 (58%)	20 (0– 80)	3 (5%)	0 (0–10)
bcl-2	26 (33%)	10 (0–70)	3 (5%)	3 (0–20)
p53	29 (37%)	0.1 (0– 50)	1 (2%)	0 (0–5)
Ki-67	36 (46%)	1 (0–20)	1 (2%)	0 (0–10)
p120	46 (58%)	10 (0–50)	5 (8%)	0.1 (0–20)
MVD	29 (37%)	20 (0.1–50)	ND

Also listed are the number and percentage of cases in which the immunopositive cells were raised above the defined cut off limits.

*Percentage of immunopositive cells/specimen.

EGFR, epidermal growth factor receptor; MVD, microvessel density; ND, not defined.